Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anlotinib”

451 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 451 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07376499
What this trial is testing

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

Who this might be right for
Small Cell Lung Cancer
China Medical University, China 31
Testing effectiveness (Phase 2)UnknownNCT04979585
What this trial is testing

Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma

Who this might be right for
Melanoma
Di Wu 66
Testing effectiveness (Phase 2)UnknownNCT04725214
What this trial is testing

Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma

Who this might be right for
MGMT-Unmethylated Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07231575
What this trial is testing

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

Who this might be right for
Neoadjuvant ImmunotherapyNSCLCChemo-free Therapy
Sun Yat-sen University 39
Testing effectiveness (Phase 2)UnknownNCT03735264
What this trial is testing

Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）

Who this might be right for
Non Small Cell Lung Cancer
The Affiliated Hospital of Qingdao University 46
Testing effectiveness (Phase 2)Looking for participantsNCT05926700
What this trial is testing

Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment

Who this might be right for
Soft Tissue Sarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 27
Early research (Phase 1)UnknownNCT04659733
What this trial is testing

Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children

Who this might be right for
Sarcoma
Yizhuo Zhang 36
Testing effectiveness (Phase 2)Study completedNCT04507906
What this trial is testing

Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC

Who this might be right for
NSCLC Stage IVCheckpoint Inhibitor
Shanghai Chest Hospital 21
Testing effectiveness (Phase 2)Looking for participantsNCT04136535
What this trial is testing

Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC

Who this might be right for
NSCLC Stage IV
Fudan University 105
Large-scale testing (Phase 3)Study completedNCT02388919
What this trial is testing

Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）

Who this might be right for
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 439
Not applicableUnknownNCT03929965
What this trial is testing

Anlotinib in Advanced Solid Tumors With FGFR Alteration

Who this might be right for
Advanced Solid Tumor
Shanghai Changzheng Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04172571
What this trial is testing

The Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Akeso 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06848439
What this trial is testing

Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer

Who this might be right for
Mouth NeoplasmsNeoadjuvant TherapyImmunotherapy+1 more
Jiangsu Cancer Institute & Hospital 26
Testing effectiveness (Phase 2)UnknownNCT04895930
What this trial is testing

Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Shanghai Chest Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06978153
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Tang-Du Hospital 66
Testing effectiveness (Phase 2)Study completedNCT05001971
What this trial is testing

Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Hunan Cancer Hospital 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06429397
What this trial is testing

Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma

Who this might be right for
Pheochromocytoma
Sun Yat-sen University 22
Testing effectiveness (Phase 2)UnknownNCT05013697
What this trial is testing

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Who this might be right for
Esophageal Neoplasms
Henan Cancer Hospital 48
Testing effectiveness (Phase 2)UnknownNCT05244993
What this trial is testing

AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer

Who this might be right for
Breast Neoplasm Female
Liaoning Cancer Hospital & Institute 42
Post-approval studies (Phase 4)Looking for participantsNCT06506838
What this trial is testing

Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaDoxorubicinRadiotherapy
Guangdong Provincial People's Hospital 39
Load More Results